Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al, No. 2:15-cv-01455 (E.D. Tex. Feb. 28, 2017)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Before the Court is the Opposed Motion to Amend the Stipulated Protective Order in Civil Action No. 2:16-cv-0401 as to Defendant Famy Care Limited Only , Dkt. No. 271, filed by defendant Famy Care Ltd. (“FCL” ). FCL requests that the Protective Order governing the consolidated case be amended in FCL’ s individual case to allow two non- attorneys to view material that the plaintiff Allergan, Inc., designated “Confidential.” FCL has also filed Defendant Famy Care Limited’s Motion for In-Person Hearing, Dkt. No.